ArticleFrontiers in pharmacology2024

ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validation.

Li Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.